AD is characterised by impairment of cognitive function as well as the presence of neuropathological biomarkers, which include the well reported aggregation of insoluble β-amyloid (Aβ) and neurofibrillary tangles containing phosphorylated tau protein [3]. Here, MAPT is linked to Alzheimer disease.